{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:34:35Z","timestamp":1769765675234,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mechanisms of transmesothelial invasion of ovarian cancer are still poorly understood. Here we examined whether this phenomenon may be determined by an expression of intercellular junctions in peritoneal mesothelial cells (PMCs). Analysis of ovarian tumors showed that cancer cells are localized below an intact layer of PMCs. The PMCs located near the invaded cancer cells displayed low expression of connexin 43, E-cadherin, occludin, and desmoglein, as well as expressed SA-\u03b2-Gal, a marker of senescence. Experiments <jats:italic>in vitro<\/jats:italic> showed that senescent PMCs exhibited decreased levels of the four tested intercellular junctions, and that the invasion of ovarian cancer cells through the PMCs increased proportionally to the admixture of senescent cells. Intervention studies showed that the expression of connexin 43, E-cadherin, occludin, and desmoglein in senescent PMCs could be restored upon the blockade of p38 MAPK, NF-\u03baB, AKT, JNK, HGF, and TGF-\u03b21. When these molecules were neutralized, the efficiency of the transmesothelial cancer cell invasion was diminished. Collectively, our findings show that the integrity of the peritoneal mesothelium, which is determined by the expression of junctional proteins, is critical for the invasion of ovarian cancer. They also indicate a mechanism by which senescent PMCs may promote the invasive potential of cancer cells.<\/jats:p>","DOI":"10.1038\/s41598-019-44123-4","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T10:03:32Z","timestamp":1558346612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells"],"prefix":"10.1038","volume":"9","author":[{"given":"Martyna","family":"Paku\u0142a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Witucka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Uruski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Radziemski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"Moszy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Szpurek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Maksin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldona","family":"Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sajdak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Tykarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Miku\u0142a-Pietrasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6066-5747","authenticated-orcid":false,"given":"Krzysztof","family":"Ksi\u0105\u017cek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"key":"44123_CR1","first-page":"937","volume":"93","author":"CA Doubeni","year":"2016","unstructured":"Doubeni, C. A., Doubeni, A. R. & Myers, A. E. Diagnosis and Management of Ovarian Cancer. Am Fam Physician 93, 937\u2013944 (2016).","journal-title":"Am Fam Physician"},{"key":"44123_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4251\/wjgo.v2.i2.102","volume":"2","author":"A Fagotti","year":"2010","unstructured":"Fagotti, A. et al. Peritoneal carcinosis of ovarian origin. World J Gastrointest Oncol 2, 102\u2013108, https:\/\/doi.org\/10.4251\/wjgo.v2.i2.102 (2010).","journal-title":"World J Gastrointest Oncol"},{"key":"44123_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3322\/caac.20113","volume":"61","author":"D Jelovac","year":"2011","unstructured":"Jelovac, D. & Armstrong, D. K. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J. Clin 61, 183\u2013203 (2011).","journal-title":"CA Cancer J. Clin"},{"key":"44123_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel, E. Ovarian cancer development and metastasis. Am. J. Pathol 177, 1053\u20131064 (2010).","journal-title":"Am. J. Pathol"},{"key":"44123_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00018-017-2663-1","volume":"75","author":"J Mikula-Pietrasik","year":"2018","unstructured":"Mikula-Pietrasik, J., Uruski, P., Tykarski, A. & Ksiazek, K. The peritoneal \u201csoil\u201d for a cancerous \u201cseed\u201d: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell Mol Life Sci 75, 509\u2013525, https:\/\/doi.org\/10.1007\/s00018-017-2663-1 (2018).","journal-title":"Cell Mol Life Sci"},{"key":"44123_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fonc.2013.00097","volume":"3","author":"MP Steinkamp","year":"2013","unstructured":"Steinkamp, M. P. et al. Ovarian tumor attachment, invasion, and vascularization reflect unique microenvironments in the peritoneum: insights from xenograft and mathematical models. Front Oncol 3, 97 (2013).","journal-title":"Front Oncol"},{"key":"44123_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2018.01.002","author":"J Mikula-Pietrasik","year":"2018","unstructured":"Mikula-Pietrasik, J., Stryczynski, L., Uruski, P., Tykarski, A. & Ksiazek, K. Procancerogenic activity of senescent cells: a case of the peritoneal mesothelium. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2018.01.002 (2018).","journal-title":"Ageing Res Rev"},{"key":"44123_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.32607\/20758251-2015-7-2-17-28","volume":"7","author":"NV Krakhmal","year":"2015","unstructured":"Krakhmal, N. V., Zavyalova, M. V., Denisov, E. V., Vtorushin, S. V. & Perelmuter, V. M. Cancer Invasion: Patterns and Mechanisms. Acta Naturae 7, 17\u201328 (2015).","journal-title":"Acta Naturae"},{"key":"44123_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/IGC.0000000000000036","volume":"24","author":"S Stadlmann","year":"2014","unstructured":"Stadlmann, S. et al. Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids\u2013evidence for a mechanical and paracrine barrier function of the peritoneal mesothelium. Int. J. Gynecol. Cancer 24, 192\u2013200 (2014).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"44123_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","volume":"1","author":"MP Iwanicki","year":"2011","unstructured":"Iwanicki, M. P. et al. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov 1, 144\u2013157 (2011).","journal-title":"Cancer Discov"},{"key":"44123_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.417","volume":"7","author":"J Mikula-Pietrasik","year":"2016","unstructured":"Mikula-Pietrasik, J. et al. Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases. Cell Death. Dis 7, e2565 (2016).","journal-title":"Cell Death. Dis"},{"key":"44123_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2017.06.015","volume":"110","author":"J Mikula-Pietrasik","year":"2017","unstructured":"Mikula-Pietrasik, J. et al. Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells. Free Radic. Biol. Med 110, 270\u2013279 (2017).","journal-title":"Free Radic. Biol. Med"},{"key":"44123_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.canlet.2014.09.041","volume":"355","author":"J Mikula-Pietrasik","year":"2014","unstructured":"Mikula-Pietrasik, J. et al. Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo. Cancer Lett 355, 310\u2013315 (2014).","journal-title":"Cancer Lett"},{"key":"44123_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/2159-8290.CD-11-0117","volume":"1","author":"HA Kenny","year":"2011","unstructured":"Kenny, H. A., Nieman, K. M., Mitra, A. K. & Lengyel, E. The first line of intra-abdominal metastatic attack: breaching the mesothelial cell layer. Cancer Discov 1, 100\u2013102 (2011).","journal-title":"Cancer Discov"},{"key":"44123_CR15","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/ijc.22874","volume":"121","author":"HA Kenny","year":"2007","unstructured":"Kenny, H. A., Krausz, T., Yamada, S. D. & Lengyel, E. Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int. J. Cancer 121, 1463\u20131472 (2007).","journal-title":"Int. J. Cancer"},{"key":"44123_CR16","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1172\/JCI74778","volume":"124","author":"HA Kenny","year":"2014","unstructured":"Kenny, H. A. et al. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J. Clin Invest 124, 4614\u20134628 (2014).","journal-title":"J. Clin Invest"},{"key":"44123_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0014-4827(85)90197-1","volume":"160","author":"MJ Niedbala","year":"1985","unstructured":"Niedbala, M. J., Crickard, K. & Bernacki, R. J. Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion. Exp. Cell Res 160, 499\u2013513 (1985).","journal-title":"Exp. Cell Res"},{"key":"44123_CR18","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.febslet.2014.01.012","volume":"588","author":"N Defamie","year":"2014","unstructured":"Defamie, N., Chepied, A. & Mesnil, M. Connexins, gap junctions and tissue invasion. FEBS Lett 588, 1331\u20131338 (2014).","journal-title":"FEBS Lett"},{"key":"44123_CR19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1046\/j.1523-1755.2001.060003996.x","volume":"60","author":"T Ogawa","year":"2001","unstructured":"Ogawa, T., Hayashi, T., Yorioka, N., Kyoizumi, S. & Trosko, J. E. Hexamethylene bisacetamide protects peritoneal mesothelial cells from glucose. Kidney Int 60, 996\u20131008, https:\/\/doi.org\/10.1046\/j.1523-1755.2001.060003996.x (2001).","journal-title":"Kidney Int"},{"key":"44123_CR20","doi-asserted-by":"publisher","first-page":"e109628","DOI":"10.1371\/journal.pone.0109628","volume":"9","author":"TI Chang","year":"2014","unstructured":"Chang, T. I. et al. The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells. PLoS One 9, e109628, https:\/\/doi.org\/10.1371\/journal.pone.0109628 (2014).","journal-title":"PLoS One"},{"key":"44123_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3747\/pdi.2012.00323","volume":"35","author":"C Retana","year":"2015","unstructured":"Retana, C. et al. Alterations of intercellular junctions in peritoneal mesothelial cells from patients undergoing dialysis: effect of retinoic Acid. Perit Dial Int 35, 275\u2013287, https:\/\/doi.org\/10.3747\/pdi.2012.00323 (2015).","journal-title":"Perit Dial Int"},{"key":"44123_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.biocel.2017.09.002","volume":"92","author":"J Mikula-Pietrasik","year":"2017","unstructured":"Mikula-Pietrasik, J. et al. Malignant ascites determine the transmesothelial invasion of ovarian cancer cells. Int J Biochem Cell Biol 92, 6\u201313, https:\/\/doi.org\/10.1016\/j.biocel.2017.09.002 (2017).","journal-title":"Int J Biochem Cell Biol"},{"key":"44123_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/carcin\/bgr230","volume":"33","author":"J Cai","year":"2012","unstructured":"Cai, J. et al. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis 33, 20\u201329, https:\/\/doi.org\/10.1093\/carcin\/bgr230 (2012).","journal-title":"Carcinogenesis"},{"key":"44123_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10522-014-9505-4","volume":"15","author":"P Sosinska","year":"2014","unstructured":"Sosinska, P., Mikula-Pietrasik, J., Ryzek, M., Naumowicz, E. & Ksiazek, K. Specificity of cytochemical and fluorescence methods of senescence-associated beta-galactosidase detection for ageing driven by replication and time. Biogerontology 15, 407\u2013413 (2014).","journal-title":"Biogerontology"},{"key":"44123_CR25","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2353\/ajpath.2009.080613","volume":"174","author":"K Ksiazek","year":"2009","unstructured":"Ksiazek, K. et al. Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin. Am. J. Pathol 174, 1230\u20131240 (2009).","journal-title":"Am. J. Pathol"},{"key":"44123_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10585-015-9753-y","volume":"33","author":"J Mikula-Pietrasik","year":"2016","unstructured":"Mikula-Pietrasik, J. et al. Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo. Clin Exp Metastasis 33, 15\u201327 (2016).","journal-title":"Clin Exp Metastasis"},{"key":"44123_CR27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/1055-9965.98.14.1","volume":"14","author":"A Lukanova","year":"2005","unstructured":"Lukanova, A. & Kaaks, R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol. Biomarkers Prev 14, 98\u2013107 (2005).","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"44123_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0531-5565(02)00089-X","volume":"37","author":"M Statuto","year":"2002","unstructured":"Statuto, M., Bianchi, C., Perego, R. & Del, M. U. Drop of connexin 43 in replicative senescence of human fibroblasts HEL-299 as a possible biomarker of senescence. Exp Gerontol 37, 1113\u20131120 (2002).","journal-title":"Exp Gerontol"},{"key":"44123_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/excr.1994.1246","volume":"214","author":"HQ Xie","year":"1994","unstructured":"Xie, H. Q. & Hu, V. W. Modulation of gap junctions in senescent endothelial cells. Exp. Cell Res 214, 172\u2013176 (1994).","journal-title":"Exp. Cell Res"},{"key":"44123_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/2045-824X-4-12","volume":"4","author":"VJ Krouwer","year":"2012","unstructured":"Krouwer, V. J., Hekking, L. H., Langelaar-Makkinje, M., Regan-Klapisz, E. & Post, J. A. Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vasc. Cell 4, 12 (2012).","journal-title":"Vasc. Cell"},{"key":"44123_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke, S., Sinha, R., Levine, D. A., Sander, C. & Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun 4, 2126 (2013).","journal-title":"Nat. Commun"},{"key":"44123_CR32","doi-asserted-by":"publisher","first-page":"9071","DOI":"10.1073\/pnas.1120358109","volume":"109","author":"E Taniguchi Ishikawa","year":"2012","unstructured":"Taniguchi Ishikawa, E. et al. Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells. Proc Natl Acad Sci USA 109, 9071\u20139076, https:\/\/doi.org\/10.1073\/pnas.1120358109 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"44123_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.14348\/molcells.2014.2353","volume":"37","author":"H Jing","year":"2014","unstructured":"Jing, H. & Lee, S. NF-kappaB in cellular senescence and cancer treatment. Mol Cells 37, 189\u2013195, https:\/\/doi.org\/10.14348\/molcells.2014.2353 (2014).","journal-title":"Mol Cells"},{"key":"44123_CR34","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1074\/jbc.M114.550608","volume":"289","author":"N Batra","year":"2014","unstructured":"Batra, N. et al. Direct regulation of osteocytic connexin 43 hemichannels through AKT kinase activated by mechanical stimulation. J Biol Chem 289, 10582\u201310591, https:\/\/doi.org\/10.1074\/jbc.M114.550608 (2014).","journal-title":"J Biol Chem"},{"key":"44123_CR35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/01.RES.0000035854.11082.01","volume":"91","author":"BG Petrich","year":"2002","unstructured":"Petrich, B. G. et al. c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ Res 91, 640\u2013647 (2002).","journal-title":"Circ Res"},{"key":"44123_CR36","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.1158\/0008-5472.CAN-09-0300","volume":"69","author":"GJ Villares","year":"2009","unstructured":"Villares, G. J. et al. Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res 69, 6730\u20136737, https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-0300 (2009).","journal-title":"Cancer Res"},{"key":"44123_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbamem.2011.12.031","volume":"1828","author":"M Oyamada","year":"2013","unstructured":"Oyamada, M., Takebe, K. & Oyamada, Y. Regulation of connexin expression by transcription factors and epigenetic mechanisms. Biochim Biophys Acta 1828, 118\u2013133, https:\/\/doi.org\/10.1016\/j.bbamem.2011.12.031 (2013).","journal-title":"Biochim Biophys Acta"},{"key":"44123_CR38","doi-asserted-by":"publisher","first-page":"16472","DOI":"10.1073\/pnas.0605752103","volume":"103","author":"G Yang","year":"2006","unstructured":"Yang, G. et al. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc. Natl. Acad. Sci. USA 103, 16472\u201316477 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"44123_CR39","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3109\/0886022X.2013.817279","volume":"35","author":"RG Fu","year":"2013","unstructured":"Fu, R. G. et al. Premature senescence and cellular phenotype transformation of mesangial cells induced by TGF-B1. Ren Fail 35, 1142\u20131145, https:\/\/doi.org\/10.3109\/0886022X.2013.817279 (2013).","journal-title":"Ren Fail"},{"key":"44123_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<303::AID-IJC21>3.0.CO;2-W","volume":"80","author":"M Rieppi","year":"1999","unstructured":"Rieppi, M. et al. Mesothelial cells induce the motility of human ovarian carcinoma cells. Int. J. Cancer 80, 303\u2013307 (1999).","journal-title":"Int. J. Cancer"},{"key":"44123_CR41","doi-asserted-by":"publisher","first-page":"26793","DOI":"10.1074\/jbc.M212187200","volume":"278","author":"Y Hirashima","year":"2003","unstructured":"Hirashima, Y. et al. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells. J. Biol. Chem 278, 26793\u201326802 (2003).","journal-title":"J. Biol. Chem"},{"key":"44123_CR42","doi-asserted-by":"publisher","first-page":"e42436","DOI":"10.1371\/journal.pone.0042436","volume":"7","author":"JC Cheng","year":"2012","unstructured":"Cheng, J. C., Auersperg, N. & Leung, P. C. TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells. PLoS One 7, e42436 (2012).","journal-title":"PLoS One"},{"key":"44123_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2018.10.027","volume":"442","author":"Y Peng","year":"2018","unstructured":"Peng, Y. et al. PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination. Cancer Lett 442, 181\u2013192, https:\/\/doi.org\/10.1016\/j.canlet.2018.10.027 (2018).","journal-title":"Cancer Lett"},{"key":"44123_CR44","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.biocel.2013.07.004","volume":"45","author":"J Mikula-Pietrasik","year":"2013","unstructured":"Mikula-Pietrasik, J. et al. Bystander senescence in human peritoneal mesothelium and fibroblasts is related to thrombospondin-1-dependent activation of transforming growth factor-beta1. Int. J. Biochem. Cell Biol 45, 2087\u20132096 (2013).","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"44123_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4161\/cbt.9.2.10280","volume":"9","author":"W Wei","year":"2010","unstructured":"Wei, W., Kong, B., Yang, Q. & Qu, X. Hepatocyte growth factor enhances ovarian cancer cell invasion through downregulation of thrombospondin-1. Cancer Biol. Ther 9, 79\u201387 (2010).","journal-title":"Cancer Biol. Ther"},{"key":"44123_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1042\/BJ20110282","volume":"442","author":"MC Chang","year":"2012","unstructured":"Chang, M. C. et al. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK\/ERK and JNK pathways. Biochem J 442, 293\u2013302, https:\/\/doi.org\/10.1042\/BJ20110282 (2012).","journal-title":"Biochem J"},{"key":"44123_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/cbin.10184","volume":"38","author":"NG Yousif","year":"2014","unstructured":"Yousif, N. G. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K\/Akt pathway. Cell Biol Int 38, 85\u201391, https:\/\/doi.org\/10.1002\/cbin.10184 (2014).","journal-title":"Cell Biol Int"},{"key":"44123_CR48","doi-asserted-by":"publisher","first-page":"29178","DOI":"10.18632\/oncotarget.4932","volume":"6","author":"J Mikula-Pietrasik","year":"2015","unstructured":"Mikula-Pietrasik, J. et al. Colorectal cancer-promoting activity of the senescent peritoneal mesothelium. Oncotarget 6, 29178\u201329195 (2015).","journal-title":"Oncotarget"},{"key":"44123_CR49","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363\u20139367 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44123-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44123-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44123-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:40:09Z","timestamp":1671270009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44123-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44123"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44123-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7587"}}